Daunorubicin Hydrochloride — 20MG, Injection, box of 10 × 4 mL vials

Daunorubicin Hydrochloride — 20MG, Injection, box of 10 × 4 mL vials

Daunorubicin Hydrochloride is a injection for intravenous use. Daunorubicin hydrochloride in combination with other approved anticancer drugs is indicated for remission induction in acute nonlymphocytic leukemia (myelogenous, monocytic, erythroid) of adults and for remission induction in acute lymphocytic leukemia of children and adults.

• Active ingredient or product type: DAUNORUBICIN HYDROCHLORIDE
• Strength/concentration: 20MG
• Dosage form and route: Injection, Intravenous
• Exact package presentation: box of 10 × 4 mL vials
• NDC/item number: 0143-9551-10
• Manufacturer: HIKMA PHARMACEUTICALS USA INC
• Storage/handling: Store unopened vials in refrigerator, 2° to 8°C (36° to 46°F). Store prepared solution for infusion at room temperature, 15° to 30°C (59° to 86°F) for up to 24 hours. Discard unused portion.
• Status: Rx only

Important safety information: Review the current product labeling for product-specific contraindications, warnings, and precautions before use.

Refer to the current product labeling for complete indications, preparation or administration instructions, contraindications, warnings, precautions, and storage requirements.